{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-097076","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2023-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.208174+00:00","generated_at":"2026-06-07T09:54:17.043607+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"InMed shareholders elect all director nominees at 2023 AGM","bullets":["Eric A. Adams re-elected with 76.09% of votes cast; 23.91% withheld.","All five director nominees (Adams, Hull, Grove, Baldasare, Lemerond) received over 66% support.","Shareholders approved Marcum LLP as independent auditor with 90.45% of votes cast.","Total turnout: 1,292,647 shares (38.84% of 3,328,191 outstanding shares)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-097076","json":"https://secwatch.observer/filing/0001213900-23-097076.json","markdown":"https://secwatch.observer/filing/0001213900-23-097076.md","text":"https://secwatch.observer/filing/0001213900-23-097076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390023097076/0001213900-23-097076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390023097076/ea190383-8k_inmedpharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:54:17.043607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"409bd55aa6f86d485bf6e1b3e3eb9fd8b17d5c8d","claim":"InMed Pharmaceuticals Inc. shareholders approved Appointment of Independent Registered Public Accounting Firm at the 2023-12-19 meeting.","evidence_excerpt":"Proposal No. 2—Appointment of Independent Registered Public Accounting Firm The Corporation’s shareholders voted to approve the appointment of Marcum LLP as the independent registered public accounting firm of the Corporation until the 2024 Annual General Meeting of Shareholders or until a successor is named. Votes For % Votes For Vote Against % Votes Against Abstain Broker Non- Votes 1,169,259 90.45% 0 0% 123,387 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390023097076/0001213900-23-097076-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-19"}],"fact_type":"shareholder_vote"},{"claim_id":"62ba3cf2037f570193694a7d25030112b566a2c9","claim":"InMed Pharmaceuticals Inc. shareholders approved Election of Directors at the 2023-12-19 meeting.","evidence_excerpt":"Proposal No. 1—Election of Directors The Corporation’s shareholders voted to elect the following persons to the board of directors of the Corporation, each to serve until the 2024 Annual General Meeting of Shareholders: Nominee Votes For % Votes For Votes Withheld % Votes Withheld Broker Non-Votes Eric A. Adams 160,711 76.09% 50,513 23.91% 1,081,422 Andrew Hull 141,398 66.94% 69,826 33.06% 1,081,422 Janet Grove 141,882 67.17% 69,342 32.83% 1,081,422 Bryan Baldasare 145,659 68.96% 65,565 31.04% 1,081,422 Nicole Lemerond 145,865 69.06% 65,359 30.94% 1,081,422","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390023097076/0001213900-23-097076-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-19"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}